Chapter 1687: Chapter 1691: Chen Cang Is Here! (Seventh Update)
Tethys was not someone who enjoyed attending conferences.
He believed that researchers needed to communicate with their peers, not with those capitalists.
Of course!
Capitalists need to be cajoled, after all, they are the money sponsors, the ATM machines, you need to regularly get money from them.
So, for these academic conferences organized by the bosses, he simply smiled and declined.
Then he’d come back and toss it in the trash can.
John smiled and said, "Perhaps we could try our luck, what do you think?"
Tethys nodded, "Sure!"
Now, he no longer had the glory of the past.
Everything must start anew.
Sometimes, the fear isn’t about lacking money or technology, but that one no longer possesses the humble heart of the past.
Tethys adjusted his mindset in a single day, transitioning from someone confident about vying for a Nobel Prize to starting over, and all this was not simple.
He seriously accepted the ticket, smiling as he unfolded it and held it to his mouth: "I smell the scent of hope!"
...
...
Chen Cang got off the plane, and Yotel from Nature magazine came to meet him personally.
When Chen Cang informed Yotel of his desire to recruit people and attract investment.
Yotel invited Chen Cang to participate in this conference held in New York.
This conference gathered many investors, as well as engineers from pharmaceutical companies, and many researchers and laboratories seeking investors.
These conferences were like a miniature venture capital market.
However, these investments were in scientific research, buying into hopes.
But, these companies weren’t foolish, actually, more often than not, they preferred acquiring patents over investments.
After all, investing in a team of researchers oneself is much cheaper than direct purchase, and sometimes these laboratories also function as outsourcing units.
For example, Pfizer is good at developing oncology drugs, and when it encounters a minor issue it wants to research but lacks the relevant team, building it from scratch requires huge investment and time, at that moment, instead of choosing to cooperate with Johnson & Johnson or Roche, it outsources those minor issues.
Many small labs actually primarily profit this way.
This is why foreign research institutions have proliferated, which is not an exaggeration.
Of course, for those star projects, these companies have money they can invest to let you research.
For instance, Howard’s Eckes company’s x-pri technology was favored directly by Johnson & Johnson, exchanging shares plus investment.
Chen Cang came here today with a simple purpose, he needed money!
But!
He didn’t want to sell Parkinson’s technology so early; he was here to sell another technology.
New stereotactic technology!
Chen Cang needed money now, it was no choice, as Wan He Group was just starting up, and spending money on factory equipment and production lines.
Over there, there was also a money-draining beast in the UK developing a cardiac resuscitation fluid, spending money like water.
Now!
Chen Cang also considered collaborating with departments like the Chinese Academy of Sciences, Ministry of Science and Technology, and the Health and Hygiene Committee for his research lab here.
But after much thought, Chen Cang refused!
After all, once you take people’s money.
You are destined to be under their control.
That’s policy!
So, instead of doing that, it’s better to find ways to raise money on his own.
He didn’t want to sell shares to capitalists either.
Still didn’t want to transfer Parkinson’s technology.
Ultimately, the most suitable thing was the reward he received, the "New Stereotactic Instrument".
Besides that, there was one more thing!
It was the imaging guide for Google’s company’s microscopy stereoscopic imaging technology only mastered by him.
During this time, Bruce, who was mainly responsible for the project at Google’s company, and the chief engineer Walter, also came to New York for a meeting.
Chen Cang was here this time for these two matters.
Let’s see how much they can sell for!
It would be best if they could be sold as a package.
Actually, Chen Cang preferred completion of the acquisition by Google’s company.
Because he knew that Google had the capability.
Moreover, microscopic imaging technology and the new stereotactic instrument could be integrated.
Once combined, the effects produced would be even more remarkable!
Why didn’t Chen Cang sell them domestically?
Very simple...
The sale price wouldn’t be high!
Chen Cang wasn’t doing charity.
He also wanted to get a good price.
On the same day, Yotel, the editor-in-chief of Nature magazine, escorted Chen Cang to the hotel for a little rest, and then they arrived at the venue.
Chen Cang didn’t have much time to delay.
The one-week promise was already on the sixth day!
Tomorrow, Chen Cang was to take a huge sum of money back to the country.
His mental price was 500 million US Dollars!
With these 500 million US dollars in hand, he believed the construction of the laboratory should encounter no great problems?
The conference had not yet started, but there were already quite a few people in the large venue.
Yotel’s arrival attracted a lot of people’s attention.
After all, he was the editor-in-chief of Nature, a person of significant status.
However, when Yotel introduced Chen Cang to everyone, it immediately attracted the attention of all in the room.
"Chen Cang! Professor Chen?"
"That surgical prodigy?"
"No, now he is a research prodigy!"
"That’s right! I read that paper; it makes perfect sense, Professor Chen Cang’s understanding of Parkinson’s has already surpassed everyone, including Professor Tethys!"
"It’s actually Professor Chen! Why is he here?"
"Could it be... for patents?"
For a moment!
As soon as Chen Cang appeared in the venue, more and more people started making calls to their companies.
As an international metropolis, many large pharmaceutical groups had subsidiaries in New York.
Upon learning that Chen Cang showed up at the venue, they immediately dispatched branch managers to attend and maintain constant contact with the headquarters.
This time, Chen Cang’s research on Parkinson’s had already attracted the attention of these large pharmaceutical companies.
In the eyes of everyone, Chen Cang was simply a tempting hot cake!
In the afternoon, when Tethys and John brought their research findings to the venue, they were suddenly slightly stunned.
Tethys was someone who had seen big scenes, but... even so, he was a bit surprised.
Why were there so many bigwigs at this venue?
Most of the giants from New York’s pharmaceutical companies had come, with general manager-level individuals personally attending.
This scene left Tethys somewhat shocked!
What on earth was the reason?
What happened?
But he quickly learned why.
Because he saw a familiar figure in the crowd: Chen Cang!
Upon seeing him, Tethys felt a swirl of emotions inside.
He who once towered above, even planned to scheme against Chen Cang to obtain his research results on Parkinson’s.
And now...
At such a conference.
Chen Cang had become someone admired by all, yet he... was seldom attended to.
In the eyes of capital, he was no longer the leading figure in the field of Parkinson’s.
Thinking of this, Tethys would definitely be lying if he said he didn’t regret it.
If given a chance to turn back, he would absolutely not refuse!